Almaaytah Ammar, Abualhaijaa Ahmad, Alqudah Obadah
Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Department of Applied Biological Sciences, Faculty of Science and Arts, Jordan University of Science and Technology, Irbid, Jordan.
Infect Drug Resist. 2019 May 23;12:1371-1380. doi: 10.2147/IDR.S204626. eCollection 2019.
Antimicrobial resistance toward antibiotics is reaching historical unprecedented levels. There is an urgent and imminent need to develop novel antimicrobial alternatives. Antimicrobial peptides could prove to be a successful group of antimicrobials for drug development. Recently, we have designed a novel synthetic peptide named AamAP1-Lysine. The peptide displayed potent wide-spectrum antimicrobial activities against Gram-positive and Gram-negative bacteria. The purpose of this study is to evaluate the antimicrobial effect of combining AamAP1-Lysine with five different conventional antibiotics each representing a distinct mechanism of action in order to explore the possibility of producing a synergistic mode of action against a resistant strain of Gram-positive and a resistant strain of Gram-negative bacteria. The antimicrobial activity of AamAP1-Lysine in combination with five different antibiotics were evaluated for their antimicrobial activity employing standard antimicrobial assays, the synergistic activity of the peptide-antibiotic combinations were evaluated using checkerboard technique in addition to real-time time-kill assays. For the antibiofilm studies, the MBEC values were determined by employing the Calgary device. The combination strategy displayed potent synergistic activities against planktonic bacteria in a significant number of peptide-antibiotic combinations. The synergistic activity managed to reduce the effective minimum inhibitory concentration (MIC) concentrations dramatically with some combinations exhibiting a 64-fold decrease in the effective MIC of AamAP1-Lysine individually. Additionally, the combined synergistic activities of the peptide antibiotics were evaluated, and our results have identified two peptide antibiotic combinations with potent synergistic activities against biofilm growing strains of resistant bacteria. Our results clearly indicate that peptide-antibiotic combinations could prove to be a very effective strategy in combatting multidrug-resistant bacteria and biofilm caused infections.
对抗生素的耐药性正达到前所未有的历史水平。迫切需要开发新型抗菌替代品。抗菌肽可能被证明是用于药物开发的一类成功的抗菌剂。最近,我们设计了一种名为AamAP1-Lysine的新型合成肽。该肽对革兰氏阳性菌和革兰氏阴性菌显示出强大的广谱抗菌活性。本研究的目的是评估AamAP1-Lysine与五种不同的传统抗生素联合使用的抗菌效果,每种抗生素代表一种独特的作用机制,以探索对革兰氏阳性耐药菌株和革兰氏阴性耐药菌株产生协同作用模式的可能性。采用标准抗菌试验评估AamAP1-Lysine与五种不同抗生素联合使用时的抗菌活性,除实时杀菌试验外,还使用棋盘法评估肽-抗生素组合的协同活性。对于抗生物膜研究,使用卡尔加里装置测定最低生物被膜消除浓度(MBEC)值。在大量的肽-抗生素组合中,联合策略对浮游细菌显示出强大的协同活性。协同活性成功地显著降低了有效最低抑菌浓度(MIC),一些组合使AamAP1-Lysine单独使用时的有效MIC降低了64倍。此外,还评估了肽抗生素的联合协同活性,我们的结果确定了两种对耐药细菌的生物膜生长菌株具有强大协同活性的肽抗生素组合。我们的结果清楚地表明,肽-抗生素组合可能被证明是对抗多重耐药细菌和生物膜引起的感染的一种非常有效的策略。